StonvexLoading…
StonvexStonvexStonvexCore line items from RPAY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $309.26M | $313.04M | $296.63M | $279.23M |
Operating Income | $-254.72M | $-7.77M | $-111.41M | $-47.20M |
Net Income | $-256.72M | $-10.16M | $-110.49M | $12.84M |
EPS (Diluted) | $-3.00 | $-0.11 | $-1.23 | $0.12 |
Total Assets | $1.20B | $1.57B | $1.52B | $1.63B |
Total Liabilities | $717.97M | $798.74M | $689.04M | $698.51M |
Cash & Equivalents | $115.69M | $189.53M | $118.10M | $64.89M |
Free Cash Flow OCF − CapEx | $90.83M | $149.10M | $102.88M | $71.05M |
Shares Outstanding | 85.56B | 89.92B | 90.05B | 110.67B |